Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.
Expert Opin Ther Targets. 2017 Feb;21(2):145-157. doi: 10.1080/14728222.2017.1272580. Epub 2016 Dec 26.
Expert Opin Ther Targets. 2017.
PMID: 28019723
Review.
Targeting HIF-2α as therapy for advanced cancers.
Murugesan T, Rajajeyabalachandran G, Kumar S, Nagaraju S, Jegatheesan SK.
Murugesan T, et al. Among authors: rajajeyabalachandran g.
Drug Discov Today. 2018 Jul;23(7):1444-1451. doi: 10.1016/j.drudis.2018.05.003. Epub 2018 May 16.
Drug Discov Today. 2018.
PMID: 29753878
Review.
Item in Clipboard
SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer.
Prashanth S, Radha Maniswami R, Rajajeyabalachandran G, Jegatheesan SK.
Prashanth S, et al. Among authors: rajajeyabalachandran g.
Drug Discov Today. 2024 May;29(5):103982. doi: 10.1016/j.drudis.2024.103982. Epub 2024 Apr 16.
Drug Discov Today. 2024.
PMID: 38614159
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.